Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle.
about
Junctophilin 1 and 2 proteins interact with the L-type Ca2+ channel dihydropyridine receptors (DHPRs) in skeletal muscleDepression of voltage-activated Ca2+ release in skeletal muscle by activation of a voltage-sensing phosphatase.Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutantsThe elusive role of the SPRY2 domain in RyR1.Sarcoplasmic reticulum Ca2+ permeation explored from the lumen side in mdx muscle fibers under voltage controlIn cellulo phosphorylation induces pharmacological reprogramming of maurocalcin, a cell-penetrating venom peptideCharged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor.Voltage-activated elementary calcium release events in isolated mouse skeletal muscle fibers.Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.Model calcium sensors for network homeostasis: sensor and readout parameter analysis from a database of model neuronal networks.Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcineMaurocalcin phosphorylated at threonin 26 maintains its activity on ryanodine receptor-mediated Ca2+ release in intact muscle fibersMaurocalcine interacts with the cardiac ryanodine receptor without inducing channel modificationSpontaneous and voltage-activated Ca2+ release in adult mouse skeletal muscle fibres expressing the type 3 ryanodine receptor.Impaired excitation-contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy.Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.Phosphoinositide substrates of myotubularin affect voltage-activated Ca²⁺ release in skeletal muscle.
P2860
Q24624889-6E983560-762B-4B6E-B051-D5325839D7F6Q30634133-91547BD4-A24C-49E6-92E9-A94A3123D011Q34545457-56A68352-BEF0-44E4-A872-1EF16D5F7F4EQ35079050-D011B651-3B0F-47B0-B6CB-F5B760BF8D32Q35789210-E72D4E65-0B58-4A76-97E0-07056A733742Q36866096-301DFF2E-E366-4F66-A7EA-30375980F9F4Q36899908-2FE00B13-90FC-4D8B-BF72-B4427CE64711Q37485183-9D6CD745-DC6E-4F04-988D-E531BB980E06Q37515114-98AE0D4C-9A97-45E9-92AA-7F44F9530B51Q39943936-148BD182-4BE2-426D-9A13-0E78F00A17C9Q41856696-BF29385E-ADCA-4509-BDF9-64124BBF3123Q42183581-1459FBF9-795A-4466-883E-79C670822A89Q42389534-40808C18-E922-4B0A-98DF-C8CFB5F6A685Q42414910-74A15C29-FCD4-4D6D-90D6-BD34624C8809Q46897782-9589F271-BA54-4C8A-BB2A-B2B9EFED089DQ47601966-6EE00C44-7411-478D-AD5A-6842DBEA3E30Q50510755-C5A761E0-16ED-4032-B2FD-8BF1583F697AQ54409979-50ABD138-14DB-4A5D-A9FB-D7B9F2E7A250
P2860
Transient loss of voltage control of Ca2+ release in the presence of maurocalcine in skeletal muscle.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@ast
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@en
type
label
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@ast
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@en
prefLabel
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@ast
Transient loss of voltage cont ...... urocalcine in skeletal muscle.
@en
P2093
P2860
P50
P1433
P1476
Transient loss of voltage cont ...... aurocalcine in skeletal muscle
@en
P2093
Bruno Allard
Michel Ronjat
Sandrine Pouvreau
P2860
P304
P356
10.1529/BIOPHYSJ.105.078089
P407
P577
2006-06-16T00:00:00Z